BACKGROUND: Meningioma patients are known to face cognitive deficits before and after surgery. We examined individual changes in cognitive performance over time and identified preoperative predictors of cognitive functioning 12 months after surgery in a large sample of meningioma patients. METHODS: Patients underwent neuropsychological assessment (NPA) using CNS Vital Signs 1 day before (T0) and 3 (T3) and 12 (T12) months after surgery. Patients' sociodemographically corrected scores on 7 cognitive domains were compared with performance of a normative sample using one-sample z tests and chi-square tests of independence. Reliable change indices with correction for practice effects were calculated for individual patients. Linear mixed effects models were used to identify preoperative predictors of performance at T12. RESULTS: At T0, 261 patients were assessed, and 229 and 82 patients were retested at T3 and T12, respectively. Patients showed impaired cognitive performance before and after surgery, and although performance improved on the group level, cognitive scores remained significantly lower than in the normative sample up to T12. On the individual level, performance remained stable in the majority of patients. Better preoperative performance, younger age, male sex, and higher educational level predicted better late cognitive performance. CONCLUSIONS: Meningioma patients face serious and persistent pre- and postsurgical cognitive deficits. A preoperative NPA together with sociodemographic characteristics may provide valuable information on the late cognitive outcome of individual meningioma patients. These results can help to inform patients and clinicians on late cognitive outcomes at an early stage, and emphasizes the importance of presurgical NPA and timely cognitive rehabilitation.
BACKGROUND:Meningiomapatients are known to face cognitive deficits before and after surgery. We examined individual changes in cognitive performance over time and identified preoperative predictors of cognitive functioning 12 months after surgery in a large sample of meningiomapatients. METHODS:Patients underwent neuropsychological assessment (NPA) using CNS Vital Signs 1 day before (T0) and 3 (T3) and 12 (T12) months after surgery. Patients' sociodemographically corrected scores on 7 cognitive domains were compared with performance of a normative sample using one-sample z tests and chi-square tests of independence. Reliable change indices with correction for practice effects were calculated for individual patients. Linear mixed effects models were used to identify preoperative predictors of performance at T12. RESULTS: At T0, 261 patients were assessed, and 229 and 82 patients were retested at T3 and T12, respectively. Patients showed impaired cognitive performance before and after surgery, and although performance improved on the group level, cognitive scores remained significantly lower than in the normative sample up to T12. On the individual level, performance remained stable in the majority of patients. Better preoperative performance, younger age, male sex, and higher educational level predicted better late cognitive performance. CONCLUSIONS:Meningiomapatients face serious and persistent pre- and postsurgical cognitive deficits. A preoperative NPA together with sociodemographic characteristics may provide valuable information on the late cognitive outcome of individual meningiomapatients. These results can help to inform patients and clinicians on late cognitive outcomes at an early stage, and emphasizes the importance of presurgical NPA and timely cognitive rehabilitation.
Authors: Philipp Hendrix; Elisa Hans; Christoph J Griessenauer; Andreas Simgen; Joachim Oertel; Julia Karbach Journal: Clin Neurol Neurosurg Date: 2017-03-18 Impact factor: 1.876
Authors: Oliver Tucha; Christian Smely; Michael Preier; Georg Becker; Geraldine M Paul; Klaus W Lange Journal: J Neurosurg Date: 2003-01 Impact factor: 5.115
Authors: M Dijkstra; D van Nieuwenhuizen; L J A Stalpers; M Wumkes; M Waagemans; W P Vandertop; J J Heimans; S Leenstra; C M Dirven; J C Reijneveld; M Klein Journal: J Neurol Neurosurg Psychiatry Date: 2008-07-24 Impact factor: 10.154
Authors: Alexander Pemov; Ramita Dewan; Nancy F Hansen; Settara C Chandrasekharappa; Abhik Ray-Chaudhury; Kristine Jones; Wen Luo; John D Heiss; James C Mullikin; Prashant Chittiboina; Douglas R Stewart; Ashok R Asthagiri Journal: Sci Rep Date: 2020-07-28 Impact factor: 4.379
Authors: Isabel K Gosselt; Vera P M Scheepers; Lauriane A Spreij; Johanna M A Visser-Meily; Tanja C W Nijboer Journal: Neurooncol Pract Date: 2020-11-21
Authors: Pearl J C van Lonkhuizen; Sophie J M Rijnen; Sophie D van der Linden; Geert-Jan M Rutten; Karin Gehring; Margriet M Sitskoorn Journal: Psychooncology Date: 2019-06-20 Impact factor: 3.894
Authors: Sophie J M Rijnen; Wouter De Baene; Geert-Jan M Rutten; Karin Gehring; Margriet M Sitskoorn Journal: Neuro Oncol Date: 2020-04-15 Impact factor: 12.300
Authors: Sophie J M Rijnen; Elke Butterbrod; Geert-Jan M Rutten; Margriet M Sitskoorn; Karin Gehring Journal: Neurosurgery Date: 2020-11-16 Impact factor: 4.654
Authors: Amir H Zamanipoor Najafabadi; Pim B van der Meer; Florien W Boele; Martin J B Taphoorn; Martin Klein; Saskia M Peerdeman; Wouter R van Furth; Linda Dirven Journal: Neurooncol Adv Date: 2020-12-05
Authors: Roland Goldbrunner; Pantelis Stavrinou; Michael D Jenkinson; Felix Sahm; Christian Mawrin; Damien C Weber; Matthias Preusser; Giuseppe Minniti; Morten Lund-Johansen; Florence Lefranc; Emanuel Houdart; Kita Sallabanda; Emilie Le Rhun; David Nieuwenhuizen; Ghazaleh Tabatabai; Riccardo Soffietti; Michael Weller Journal: Neuro Oncol Date: 2021-11-02 Impact factor: 13.029